Daniel Eve explained NHS England funded off-label usage of recombinant blood products for post-pubertal children with Von Willebrand Disease. NHS England is in the early stages of considering the possibility of off-label usage for patients under 12.
Chronology Information
Date:
Chapter/issue
Access to Treatment